Abstract This study examined the relationship between generic drug market shares and the number of reported side effects. Yearly time-series data for the number of reported side effects and information on market shares, prices, and quantities from 1972 to 1996 were used in this study. Poisson and negative binomial regression models were used in the statistical analysis. The results show that increased generic market share increases the number of reported side effects for all estimated models. When studying the relationship at the substance level, increasing generic market shares increases the number of side effects for 7 of the 15 substances. Generic substitution laws and measures to increase generic competition may thus have unintended consequences since these results show a positive relationship between generic market shares and reported side effects.
market shares       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Market_share          

Poisson                       0.9999999556594058^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Poisson_distribution  

generic drug                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Generic_drug          

Generic substitution          0.9999999173061872^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Automatic_Generic_Substitution

side effects                  0.9807983626981792^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adverse_effect        

side effects                  0.9807983626981792^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adverse_effect        

negative binomial regression  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Negative_binomial_distribution

side effects                  0.9807983626981792^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adverse_effect        

market shares                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Market_share          

side effects                  0.9807983626981792^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adverse_effect        

market share                  0.9999943473226302^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Market_share          

market shares                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Market_share          

time-series                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Time_series           

side effects                  0.9807983626981792^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adverse_effect        

statistical analysis          0.999999450344868^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Statistics            

unintended consequences       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Unintended_consequences

market shares                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Market_share          

